Li Mo

20PUBLICATIONS
230CO-AUTHORS
Metabolic medicineImmunogenetics (incl. genetic immunology)Pharmaceutical delivery technologiesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 28, 2026
Hypothalamic Control of Liver Health and Disease: From Circuits to Pathophysiology and Therapies.

|Apr 20, 2026
Clinical Characteristics and Risk Factors of Immune Checkpoint Inhibitor-Related Myocarditis: A Real World Observational Study.

|Apr 13, 2026
TOX3 in hypothalamic POMC-lineage cells regulates energy balance via the PTEN-AKT signaling axis.

Qin Tang, Juan Pang, Jinhang Zhang

|Apr 02, 2026
Tirzepatide in Metabolic Diseases: Clinical Efficacy and Safety Beyond Diabetes and Obesity.

Shixuan Dong, Ying Xu, Ran Gan

|Jan 30, 2026
Chondroitin Sulfate-Based ROS-Responsive Nanoparticles Targeting Activated Myofibroblasts via CD44 Receptors for the Renal Fibrosis Therapy.

Wei Zhao, Jie Zhou, Yan Xia

|Jan 07, 2026
An H4K12la/CEBPB-AKR1C2 signaling axis modulates the mTOR pathway to regulate cisplatin resistance in lung cancer.

Wenjing Wang, Qiang He, Tianfei Fan

Pageof 4

Frequent Collaborators

4 joint publications

Yanping Li

4 joint publications

Yining Xu

3 joint publications

Qin Tang

1 joint publications

Weizhen Zhang